252 related articles for article (PubMed ID: 18498649)
1. Transcription profiling of lung adenocarcinomas of c-myc-transgenic mice: identification of the c-myc regulatory gene network.
Reymann S; Borlak J
BMC Syst Biol; 2008 May; 2():46. PubMed ID: 18498649
[TBL] [Abstract][Full Text] [Related]
2. Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas.
Ciribilli Y; Singh P; Spanel R; Inga A; Borlak J
Oncotarget; 2015 Oct; 6(31):31569-92. PubMed ID: 26427040
[TBL] [Abstract][Full Text] [Related]
3. c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma.
Ciribilli Y; Singh P; Inga A; Borlak J
Oncotarget; 2016 Oct; 7(40):65514-65539. PubMed ID: 27602772
[TBL] [Abstract][Full Text] [Related]
4. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
5. A 2-DE MALDI-TOF study to identify disease regulated serum proteins in lung cancer of c-myc transgenic mice.
Chatterji B; Borlak J
Proteomics; 2009 Feb; 9(4):1044-56. PubMed ID: 19180532
[TBL] [Abstract][Full Text] [Related]
6. DLX5 (distal-less homeobox 5) promotes tumor cell proliferation by transcriptionally regulating MYC.
Xu J; Testa JR
J Biol Chem; 2009 Jul; 284(31):20593-601. PubMed ID: 19497851
[TBL] [Abstract][Full Text] [Related]
7. Development of pulmonary bronchiolo-alveolar adenocarcinomas in transgenic mice overexpressing murine c-myc and epidermal growth factor in alveolar type II pneumocytes.
Ehrhardt A; Bartels T; Geick A; Klocke R; Paul D; Halter R
Br J Cancer; 2001 Mar; 84(6):813-8. PubMed ID: 11259097
[TBL] [Abstract][Full Text] [Related]
8. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
Alvaro-Blanco J; Martínez-Gac L; Calonge E; Rodríguez-Martínez M; Molina-Privado I; Redondo JM; Alcamí J; Flemington EK; Campanero MR
Carcinogenesis; 2009 Mar; 30(3):440-8. PubMed ID: 19126644
[TBL] [Abstract][Full Text] [Related]
9. In silico identification of transcriptional regulators associated with c-Myc.
Elkon R; Zeller KI; Linhart C; Dang CV; Shamir R; Shiloh Y
Nucleic Acids Res; 2004; 32(17):4955-61. PubMed ID: 15388797
[TBL] [Abstract][Full Text] [Related]
10. MYC-induced epigenetic activation of GATA4 in lung adenocarcinoma.
Castro IC; Breiling A; Luetkenhaus K; Ceteci F; Hausmann S; Kress S; Lyko F; Rudel T; Rapp UR
Mol Cancer Res; 2013 Feb; 11(2):161-72. PubMed ID: 23239811
[TBL] [Abstract][Full Text] [Related]
11. A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors.
Schuldiner O; Benvenisty N
Oncogene; 2001 Aug; 20(36):4984-94. PubMed ID: 11526483
[TBL] [Abstract][Full Text] [Related]
12. Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma.
Allen TD; Rodriguez EM; Jones KD; Bishop JM
Cancer Res; 2011 Sep; 71(18):6010-8. PubMed ID: 21803744
[TBL] [Abstract][Full Text] [Related]
13. c-Myc and Sp1/3 are required for transactivation of hamster telomerase catalytic subunit gene promoter.
Park NH; Guo W; Kim HR; Kang MK; Park NH
Int J Oncol; 2001 Oct; 19(4):755-61. PubMed ID: 11562751
[TBL] [Abstract][Full Text] [Related]
14. c-Myc regulates self-renewal in bronchoalveolar stem cells.
Dong J; Sutor S; Jiang G; Cao Y; Asmann YW; Wigle DA
PLoS One; 2011; 6(8):e23707. PubMed ID: 21858211
[TBL] [Abstract][Full Text] [Related]
15. Increased susceptibility to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in transgenic mice overexpressing c-myc and epidermal growth factor in alveolar type II cells.
Ehrhardt A; Bartels T; Klocke R; Paul D; Halter R
J Cancer Res Clin Oncol; 2003 Feb; 129(2):71-5. PubMed ID: 12669230
[TBL] [Abstract][Full Text] [Related]
16. The tmp gene, encoding a membrane protein, is a c-Myc target with a tumorigenic activity.
Ben-Porath I; Yanuka O; Benvenisty N
Mol Cell Biol; 1999 May; 19(5):3529-39. PubMed ID: 10207076
[TBL] [Abstract][Full Text] [Related]
17. Integrated analysis reveals candidate genes and transcription factors in lung adenocarcinoma.
Chen B; Gao S; Ji C; Song G
Mol Med Rep; 2017 Dec; 16(6):8371-8379. PubMed ID: 28983631
[TBL] [Abstract][Full Text] [Related]
18. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha.
Santoni-Rugiu E; Jensen MR; Thorgeirsson SS
Cancer Res; 1998 Jan; 58(1):123-34. PubMed ID: 9426068
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of the Sox2, c-Myc, and Oct4 promoters.
Chen H; Jin K; Song J; Zuo Q; Yang H; Zhang Y; Li B
J Cell Biochem; 2019 Jan; 120(1):332-342. PubMed ID: 30277598
[TBL] [Abstract][Full Text] [Related]
20. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
